← brief for 2026-09-28 · Slowing decline

Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This analysis pooled data from two large randomized trials of finerenone. It looked at people with kidney disease and type 2 diabetes who were hospitalized for heart failure. It found that finerenone still slowed kidney decline after the hospital stay. This is a large trial with hard endpoints.

Who did this work

Shafi T · Anker SD · Pitt B · Ruilope LM · Rossing P · Brinker M · Rohwedder K · Scott C · Farag YMK · Filippatos G · FIDELIO-DKD and FIGARO-DKD Investigators

Source

Article · PubMed, the drug frontier · 2026 Sep 28
https://pubmed.ncbi.nlm.nih.gov/42803273/